These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2084074)

  • 1. Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.
    Robins HI; Neuberg DS; Benson AB; Pandya KJ; Tormey DC
    Invest New Drugs; 1990 Nov; 8(4):397-9. PubMed ID: 2084074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
    Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
    Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of lonidamine in metastatic breast cancer.
    Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
    Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
    Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: results from a multicenter prospective randomized trial.
    Amadori D; Frassineti GL; De Matteis A; Mustacchi G; Santoro A; Cariello S; Ferrari M; Nascimben O; Nanni O; Lombardi A; Scarpi E; Zoli W
    Breast Cancer Res Treat; 1998 Jun; 49(3):209-17. PubMed ID: 9776504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
    Stahl M; Schmoll E; Becker H; Schlichter A; Hoffmann L; Wagner H; Possinger K; Müller W; Köllermann M; Weidenhammer W
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):33-7. PubMed ID: 2031196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lonidamine in the treatment of breast cancer patients.
    Rosso R; Gardin G; Pronzato P; Camoriano A; Merlini L; Naso C; Rosso M; Barone C; Nascimben O; Ianniello G
    Ann N Y Acad Sci; 1993 Nov; 698():349-56. PubMed ID: 8279774
    [No Abstract]   [Full Text] [Related]  

  • 8. Lonidamine in metastatic breast cancer.
    Rosso R; Amoroso D; Gardin G; Miglietta L; Guido T; Pace M; Repetto L; Pronzato P
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):62-5. PubMed ID: 2031200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other options in the treatment of advanced breast cancer.
    Cobleigh MA
    Semin Oncol; 2011 Jun; 38 Suppl 2():S11-6. PubMed ID: 21600380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM).
    Gebbia V; Borsellino N; Testa A; Latteri MA; Milia V; Valdesi M; Giotta F; Gebbia N; Colucci G
    Anticancer Drugs; 1997 Nov; 8(10):943-8. PubMed ID: 9436637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
    Passalacqua R; Bisagni G; Bertusi M; Donati D; Buzzi F; Di Costanzo F; Basurto C; Gori S
    Tumori; 1989 Jun; 75(3):277-9. PubMed ID: 2672481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lonidamine in high-risk breast cancer patients.
    Possinger K; Wagner H; Kovacs S; Flath B; Classen S; Wilmanns W
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):58-61. PubMed ID: 2031199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I toxicologic study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():56-9. PubMed ID: 6717896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.
    Mansi JL; de Graeff A; Newell DR; Glaholm J; Button D; Leach MO; Payne G; Smith IE
    Br J Cancer; 1991 Sep; 64(3):593-7. PubMed ID: 1911204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs in metastatic breast cancer: an update.
    Arslan C; Altundag K; Dizdar O
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):647-67. PubMed ID: 22122529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():66-8. PubMed ID: 6717898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early observations on the administration of Lonidamine in cancer patients.
    Barduagni A; Barduagni M; Di Lauro L; Nardi M; Gallo Curcio C; Tonachella R; Ciottoli GB; Delle Chiaie S
    Oncology; 1984; 41 Suppl 1():78-81. PubMed ID: 6717900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
    Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II evaluation of combination chemotherapy plus aminoglutethimide in women with metastatic or recurrent breast carcinoma. An Eastern Cooperative Oncology Group Pilot Study.
    Grem JL; Falkson G; Love RR; Tormey DC
    Am J Clin Oncol; 1988 Oct; 11(5):528-34. PubMed ID: 3177253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.